Showing results (1-10 of 157) with videos related to
Sort By:
Pageof 16
Current Pharmaceutical Design|November 1, 2006
No-reflow: a heterogeneous clinical phenomenon with multiple therapeutic strategiesLeonarda Galiuto, Filippo CreaSN Comprehensive Clinical Medicine|August 25, 2020
Let Us Not Forget Cardiovascular Diseases During COVID-19 Pandemic: the Role of Cardiac Prevention and RehabilitationLeonarda Galiuto, Filippo CreaJournal of the American College of Cardiology|July 18, 2009
Myocardial no-reflow in humansGiampaolo Niccoli, Francesco Burzotta, Leonarda Galiuto, et al.European Heart Journal. Case Reports|February 18, 2021
'The bubble heart': an unusual natural history told by multimodality imaging- a case reportGabriella Locorotondo, Elisa Fedele, Carmela Napolitano, et al.Journal of the American College of Cardiology|July 4, 2015
The Multifaceted Clinical Readouts of Platelet Inhibition by Low-Dose AspirinCarlo PatronoBritish Journal of Clinical Pharmacology|June 19, 2016
Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspectiveCarlo PatronoEuropean Heart Journal|June 5, 2024
Low-dose aspirin for the prevention of atherosclerotic cardiovascular diseaseCarlo PatronoThe Journal of Pharmacology and Experimental Therapeutics|June 6, 2023
Cyclooxygenase Inhibitors and Cancer: The Missing PiecesCarlo PatronoClinical Therapeutics|December 4, 2014
Role of clinical pharmacology in the development of antiplatelet drugsCarlo PatronoPageof 16